Walgreens Boots Alliance Inc (WBA) Shares Bought by We Are One Seven LLC
We Are One Seven LLC boosted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 52.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,506 shares of the pharmacy operator’s stock after acquiring an additional 9,420 shares during the quarter. We Are One Seven LLC’s holdings in Walgreens Boots Alliance were worth $1,740,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Oregon Public Employees Retirement Fund raised its stake in Walgreens Boots Alliance by 12,422.1% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 34,807,507 shares of the pharmacy operator’s stock valued at $509,000 after acquiring an additional 34,529,539 shares during the period. Bank of New York Mellon Corp raised its position in shares of Walgreens Boots Alliance by 71,970.7% in the third quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock valued at $848,617,000 after purchasing an additional 11,624,703 shares during the period. Norges Bank acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth about $589,781,000. Boston Partners lifted its stake in shares of Walgreens Boots Alliance by 3,449.3% during the 4th quarter. Boston Partners now owns 3,973,944 shares of the pharmacy operator’s stock worth $271,540,000 after buying an additional 3,861,981 shares during the last quarter. Finally, Capital World Investors boosted its holdings in shares of Walgreens Boots Alliance by 18.2% during the 3rd quarter. Capital World Investors now owns 18,089,012 shares of the pharmacy operator’s stock worth $1,318,689,000 after buying an additional 2,790,213 shares during the period. 63.07% of the stock is currently owned by institutional investors and hedge funds.
Several equities research analysts have issued reports on the stock. BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, March 6th. UBS Group dropped their price target on Walgreens Boots Alliance from $70.00 to $65.00 and set a “sell” rating for the company in a report on Monday, March 4th. Cowen restated a “hold” rating and issued a $66.00 price target on shares of Walgreens Boots Alliance in a research note on Sunday, March 31st. Goldman Sachs Group lowered Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a report on Friday, December 14th. Finally, Barclays dropped their target price on Walgreens Boots Alliance from $78.00 to $60.00 and set an “equal weight” rating for the company in a report on Wednesday, April 3rd. Five investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the stock. Walgreens Boots Alliance has a consensus rating of “Hold” and an average price target of $68.50.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.70 by ($0.06). Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The business had revenue of $34.53 billion during the quarter, compared to the consensus estimate of $34.57 billion. During the same quarter in the previous year, the business posted $1.73 EPS. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, research analysts predict that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 12th. Stockholders of record on Friday, February 15th were paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.23%. The ex-dividend date of this dividend was Thursday, February 14th. Walgreens Boots Alliance’s payout ratio is 29.24%.
In other news, COO Ornella Barra purchased 18,000 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were purchased at an average cost of $54.56 per share, with a total value of $982,080.00. Following the completion of the purchase, the chief operating officer now owns 26,425 shares of the company’s stock, valued at approximately $1,441,748. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: Why is the conference call important?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.